Skip to main content

Sjögren’s Syndrome in Australia: Clinical Practice and Research

  • Chapter
  • First Online:
Sjögren’s Syndrome

Abstract

Sjögren’s syndrome is commonly encountered in clinical practice in Australia. Management is conservative and biological therapies have yet to be approved for use. Intravenous immunoglobulins have improved autonomic symptoms in some patients. Research has focused on the molecular and genetic analysis of anti-Ro/La antibodies; characterization of muscarinic receptor autoantibodies; immunohistology of salivary gland biopsies; and the role of BAFF/BLyS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Swaminathan S, Goldblatt F, Dugar M, Gordon TP, Roberts-Thomson PJ. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis. Intern Med J. Epub 2008;38:897–903.

    Article  CAS  Google Scholar 

  2. Smith AJ, Jackson MW, Wong F, Cavill D, Rischmueller M, Gordon TP. Neutralisation of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren’s syndrome. Hum Immunol. 2005;66:411–6.

    Article  PubMed  CAS  Google Scholar 

  3. McCluskey J, Farris AD, Keech CL, et al. Determinant spreading: lessons from animal models and human disease. Immunol Rev. 1998;164:209–29.

    Article  PubMed  CAS  Google Scholar 

  4. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndrome. Arthritis Rheum. 2000;43:1647–1654.

    Article  PubMed  CAS  Google Scholar 

  5. Azis KE, McCluskey PJ, Wakefield D. Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjögren’s syndrome. Ann Rheum Dis. 1997;56:140–143.

    Article  Google Scholar 

  6. Cuello C, Palladinetti P, Tedla N, DiGirolamo N, Lloyd AR, McCluskey PJ, Wakefield D. Chemokine expression and leucocyte infiltration in Sjögren’s syndrome. Br J Rheumatol. 1998;37:779–83.

    Article  PubMed  CAS  Google Scholar 

  7. Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS over-expression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest. 2002;109:59–68.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tom Gordon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Gordon, T., Rischmueller, M. (2011). Sjögren’s Syndrome in Australia: Clinical Practice and Research. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-957-4_25

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-60327-956-7

  • Online ISBN: 978-1-60327-957-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics